The proband underwent genetic testing with a 7-gene high-risk hereditary colon cancer panel which screened for variants in the APC, EPCAM, MLH1, MSH2, MSH6, MUTYH, and PMS2 genes. This evidence concerns the gene MSH2 and colonic neoplasm.